Market Share of Global Waldenstrom's Macroglobulinemia (WM) Treatment Industry
The Waldenstrom's Macroglobulinemia (WM) treatment market is moderately competitive and consists of several major players. In terms of market share, few major players currently dominate the market. With the rising patient awareness levels and high prevalence of diseases, and a rising number of therapies and drugs, few other smaller players are expected to enter the market in the coming years. Some of the major players of the market include BeiGene, Curis, Inc., X4 Pharmaceuticals, TG Therapeutics, Pharmacyclics LLC.
Waldenstrom Macroglobulinemia Market Leaders
BeiGene
TG Therapeutics, Inc.
Curis, Inc.
X4 Pharmaceuticals, Inc.
Pharmacyclics LLC
*Disclaimer: Major Players sorted in no particular order
